GW Pharmaceuticals Added to Nasdaq Biotech Index

420Patients.com is accepting qualified medical marijuana patients and caregivers to join our network. We value every registered member and we hope to serve you in Arizona. This article brought to you by 420 community friends mmjbusinessdaily.com

GW Pharmaceuticals, a United Kingdom-based company that develops CBD-rich treatments, has been added to the Nasdaq Biotechnology Index (NBI). The NBI tracks the performance of a set of securities traded on the exchange that are classified as biotech or pharmaceutical companies. GW Pharmaceuticals is the developer of Sativex, a cannabis-based drug that is approved in […]

GW Pharmaceuticals Added to Nasdaq Biotech Index is a post from: Marijuana Business Daily – Legal, Financial and Dispensary News

Leave a Reply

Skip to toolbar